UTMD - Utah Medical Products, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5379.92M
Enterprise Value 3338.32M
Trailing P/E 22.16
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)8.89
Price/Book (mrq)3.94
Enterprise Value/Revenue 37.92
Enterprise Value/EBITDA 615.43

Trading Information

Stock Price History

Beta (3Y Monthly) 0.87
52-Week Change 3-1.21%
S&P500 52-Week Change 33.55%
52 Week High 3102.70
52 Week Low 373.98
50-Day Moving Average 394.52
200-Day Moving Average 387.38

Share Statistics

Avg Vol (3 month) 316.84k
Avg Vol (10 day) 315.3k
Shares Outstanding 53.72M
Float 3.2M
% Held by Insiders 18.56%
% Held by Institutions 175.56%
Shares Short (Aug 15, 2019) 4275.01k
Short Ratio (Aug 15, 2019) 419.82
Short % of Float (Aug 15, 2019) 49.25%
Short % of Shares Outstanding (Aug 15, 2019) 47.39%
Shares Short (prior month Jul 15, 2019) 4201.8k

Dividends & Splits

Forward Annual Dividend Rate 41.1
Forward Annual Dividend Yield 41.10%
Trailing Annual Dividend Rate 31.10
Trailing Annual Dividend Yield 31.10%
5 Year Average Dividend Yield 41.50
Payout Ratio 424.39%
Dividend Date 3Oct 3, 2019
Ex-Dividend Date 4Sep 12, 2019
Last Split Factor (new per old) 22/3
Last Split Date 3Mar 22, 1993

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 39.37%
Operating Margin (ttm)40.36%

Management Effectiveness

Return on Assets (ttm)10.76%
Return on Equity (ttm)18.98%

Income Statement

Revenue (ttm)42.73M
Revenue Per Share (ttm)11.47
Quarterly Revenue Growth (yoy)8.00%
Gross Profit (ttm)26.31M
Net Income Avi to Common (ttm)16.82M
Diluted EPS (ttm)4.49
Quarterly Earnings Growth (yoy)-18.20%

Balance Sheet

Total Cash (mrq)32.88M
Total Cash Per Share (mrq)8.84
Total Debt (mrq)433k
Total Debt/Equity (mrq)0.46
Current Ratio (mrq)12.10
Book Value Per Share (mrq)25.25

Cash Flow Statement

Operating Cash Flow (ttm)14.13M
Levered Free Cash Flow (ttm)-10.45M